Upstream Bio, Inc.
UPB
$17.63
-$0.11-0.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -104.47M | -79.18M | -62.81M | -53.40M | -40.51M |
| Total Depreciation and Amortization | 148.00K | 119.00K | 89.00K | 54.00K | 57.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.98M | 5.52M | 1.67M | -1.49M | -7.58M |
| Change in Net Operating Assets | -16.64M | -9.24M | 1.87M | -837.00K | 1.50M |
| Cash from Operations | -113.98M | -82.78M | -59.17M | -55.67M | -46.53M |
| Capital Expenditure | -558.00K | -511.00K | -511.00K | -326.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -156.73M | -286.21M | -58.97M | -106.31M | -95.80M |
| Cash from Investing | -157.29M | -286.72M | -59.49M | -106.64M | -95.80M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 273.38M | 272.77M | 282.16M | 9.41M | 9.49M |
| Repurchase of Common Stock | -- | -9.28M | -9.28M | -9.28M | -9.28M |
| Issuance of Preferred Stock | 75.00K | 150.00M | 150.00M | 149.92M | 149.92M |
| Repurchase of Preferred Stock | -- | -- | -- | -133.00K | -183.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.87M | -4.01M | -3.97M | -1.79M | -133.00K |
| Cash from Financing | 269.59M | 409.49M | 418.91M | 148.13M | 149.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.68M | 40.00M | 300.25M | -14.18M | 7.50M |